Informations sur le produit
- 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-[6-[[[[9-[(2R)-5-hydroxy-2,11-dimethyl-5-oxido-9-oxo-3,6,8,10-tetraoxa-5-phosphadodec-1-yl]-9H-purin-6-yl]amino]methyl]amino]-9H-purin-9-yl]-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
Tri-POC Tenofovir Dimer is a chemical compound that has a molecular weight of 400. It is used in the treatment of HIV/AIDS and other viral diseases. Tri-POC Tenofovir Dimer can be analysed using various physicochemical techniques, such as nuclear magnetic resonance spectroscopy, X-ray diffraction, and infrared spectroscopy. The molecule contains two tenofovir molecules connected by a linker. The chemical reactions of Tri-POC Tenofovir Dimer are catalyzed by enzymes, which are proteins that speed up biochemical reactions in the body. This drug has been proposed as a potential vaccine to help prevent outbreaks of virus infection. Mathematical modelling and computer simulations have been used to study the efficacy of Tri-POC Tenofovir Dimer in preventing HIV/AIDS and other diseases caused by viruses.
